Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PYXS Pyxis Oncology, Inc. Common Stock
$3.08 -1.28% -0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PYXS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 256.9M
Enterprise value 241.7M
Trailing PE -2.4140624329448
Forward PE -2.731029
PEG Ratio -0.42246092576534
Enterprise to EBITDA -2.826
Enterprise to revenue 21.9
Price to book MRQ 6.1847386
Price to sales TTM 23.273853

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 11.0M
EBITDA -85526000
Diluted EPS TTM -1.4
Total Cash (MRQ) 33.0M
Current ratio (MRQ) 1.337
Operating Cash Flow (TTM) -67910000

PYXS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PYXS News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.